Amended IN Assembly March 14, 2018 Amended IN Assembly March 01, 2018 CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION Assembly Bill No. 1881Introduced by Assembly Members Fong and Salas(Principal coauthor: Assembly Member Mathis)(Principal coauthor: Senator Fuller)(Coauthors: Assembly Members Cunningham, Gallagher, and Lackey)(Coauthors: Senators Vidak and Wilk)January 17, 2018 An act to add Section 101161 to the Health and Safety Code, relating to health. LEGISLATIVE COUNSEL'S DIGESTAB 1881, as amended, Fong. Valley Fever testing.Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever. This bill would encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 101161 is added to the Health and Safety Code, to read:(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
Amended IN Assembly March 14, 2018 Amended IN Assembly March 01, 2018 CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION Assembly Bill No. 1881Introduced by Assembly Members Fong and Salas(Principal coauthor: Assembly Member Mathis)(Principal coauthor: Senator Fuller)(Coauthors: Assembly Members Cunningham, Gallagher, and Lackey)(Coauthors: Senators Vidak and Wilk)January 17, 2018 An act to add Section 101161 to the Health and Safety Code, relating to health. LEGISLATIVE COUNSEL'S DIGESTAB 1881, as amended, Fong. Valley Fever testing.Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever. This bill would encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
Amended IN Assembly March 14, 2018 Amended IN Assembly March 01, 2018
Amended IN Assembly March 14, 2018
Amended IN Assembly March 01, 2018
CALIFORNIA LEGISLATURE 20172018 REGULAR SESSION
Assembly Bill No. 1881
Introduced by Assembly Members Fong and Salas(Principal coauthor: Assembly Member Mathis)(Principal coauthor: Senator Fuller)(Coauthors: Assembly Members Cunningham, Gallagher, and Lackey)(Coauthors: Senators Vidak and Wilk)January 17, 2018
Introduced by Assembly Members Fong and Salas(Principal coauthor: Assembly Member Mathis)(Principal coauthor: Senator Fuller)(Coauthors: Assembly Members Cunningham, Gallagher, and Lackey)(Coauthors: Senators Vidak and Wilk)
January 17, 2018
An act to add Section 101161 to the Health and Safety Code, relating to health.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
AB 1881, as amended, Fong. Valley Fever testing.
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever. This bill would encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. Section 101161 is added to the Health and Safety Code, to read:(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. Section 101161 is added to the Health and Safety Code, to read:(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
SECTION 1. Section 101161 is added to the Health and Safety Code, to read:
### SECTION 1.
(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.(2)A complement fixation test to determine the immunoglobulin G titer.(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.
(a)A medical provider is encouraged to order, or a city or county public health laboratory is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:
(1)An immunodiffusion test to determine the presence of immunoglobulin M antibody or immunoglobulin G antibody.
(2)A complement fixation test to determine the immunoglobulin G titer.
(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.
101161. (c)The department shall develop standardized methodology for tests ordered or usedpursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.